Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10033916HBVENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS30013901HIVENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS30038294HIVENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS20042103HPVENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS20066497HPVENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS20052205HPVENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS44008818HTLV-1ENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS44041779HTLV-1ENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TVIS44036552HTLV-1ENSG00000137869.16protein_codingCYP19A1YesNo1588P11511
Q05CU4
Q8IYG4
TCGA Plot Options
Drug Information
GeneCYP19A1
DrugBank IDDB16236
Drug NameMitapivat
Target IDBE0002090
UniProt IDP11511
Regulation Typeinhibitor
PubMed IDs34987744
CitationsAl-Samkari H, van Beers EJ: Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias. Ther Adv Hematol. 2021 Dec 21;12:20406207211066070. doi: 10.1177/20406207211066070. eCollection 2021.
GroupsApproved; Investigational
Direct Classification
SMILESO=C(N1CCN(CC2CC2)CC1)C1=CC=C(NS(=O)(=O)C2=CC=CC3=C2N=CC=C3)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL4299940